1.

Which of the following has applied to the Central Drugs Standard Control Organisation for approval of Phase-III clinical trial of Molnupiravir Capsules, to be used for the treatment of Covid-19 positive patients?

A. Natco Pharma Limited
B. Astra Zeneca Pharma Limited
C. SAS Pharmaceuticals
D. ZENERIS PHARMA PVT. LTD.
E. Gracure Pharmaceuticals Limited
Answer» B. Astra Zeneca Pharma Limited


Discussion

No Comment Found